168 results
Page 8 of 9
8-K
EX-10.2
nqwsa
30 Aug 21
Target Acquisition Has Operational and Sales Footprint in Europe,Asia, and the Middle East
9:15am
8-K
EX-10.4
f63eu00
30 Aug 21
Target Acquisition Has Operational and Sales Footprint in Europe,Asia, and the Middle East
9:15am
8-K
EX-10.1
r0go8t
10 May 21
Entry into a Material Definitive Agreement
5:24pm
8-K
EX-10.1
0u6z13nisjutm 40c12
26 Feb 21
Entry into a Material Definitive Agreement
5:10pm
8-K
EX-10.2
o5jy0dvx1y 0bhdh59
26 Feb 21
Entry into a Material Definitive Agreement
5:10pm
8-K
EX-10.2
wkdi70idoatrxucpv
26 Jan 21
Aditxt Secures $5 Million Financing to Scale AditxtScore™ Operational Capacity
9:24am
8-K
EX-10.1
qpjy ivqgvqo
26 Jan 21
Aditxt Secures $5 Million Financing to Scale AditxtScore™ Operational Capacity
9:24am
8-K
EX-10.3
skpkgnp73 me3kfujqk
26 Jan 21
Aditxt Secures $5 Million Financing to Scale AditxtScore™ Operational Capacity
9:24am
8-K
EX-10.1
vjh13jo j56dbauru534
20 Nov 20
Entry into a Material Definitive Agreement
9:42pm
8-K
EX-10.2
ofc7jl3un2o7mio 81mu
14 Sep 20
Aditx Therapeutics Announces Pricing of $9.6 Million Follow-On Public Offering
4:31pm
8-K
EX-10.1
gdm28fzofjpvo9gnr
14 Sep 20
Aditx Therapeutics Announces Pricing of $9.6 Million Follow-On Public Offering
4:31pm
8-K
EX-10.1
aepkqlr h2jaojv44
20 Aug 20
Entry into a Material Definitive Agreement
8:00am
10-Q
EX-10.1
6ac1qm792gtv5pja
13 Aug 20
Quarterly report
5:24pm